(Q51322897)

English

Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice.

scientific article published on 9 May 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Lactobacillus johnsonii

object named as

Lactobacillus johnsonii

1 reference

based on heuristic

inferred from title

author name string

Jinge Xin

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Dong Zeng

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Hesong Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Xueqin Ni

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Dan Yi

5

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Kangcheng Pan

6

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Bo Jing

7

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

language of work or name

0 references

publication date

9 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Applied Microbiology and Biotechnology

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

98

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

15

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

6817-6829

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Protective role of sodium selenite on histopathological lesions, decreased T-cell subsets and increased apoptosis of thymus in broilers intoxicated with aflatoxin B₁.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Pathogenesis of non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Novel insights into the pathophysiology of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Role of the intestinal microbiome in liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

The role of oxidative stress in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Obesity alters gut microbial ecology

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Microbial ecology: human gut microbes associated with obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Targeting mitochondria: a new promising approach for the treatment of liver diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Mitochondrial adaptations to obesity-related oxidant stress

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Mitochondrial DNA damage and dysfunction, and oxidative stress are associated with endoplasmic reticulum stress, protein degradation and apoptosis in high fat diet-induced insulin resistance mice

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5752-1

21 January 2018

Identifiers

10.1007/S00253-014-5752-1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24811405

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51322897&oldid=2210811530"